Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
NCT ID: NCT05238077
Last Updated: 2022-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2018-02-26
2020-06-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this pilot study is to determine whether VL-UVA1 or NB-UVB phototherapy more efficiently induces repigmentation in patients with generalized vitiligo.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224
Narrowband UVB Treatment in Patients With Vitiligo
NCT00398723
NB-UVB and PUVA Vitiligo Study
NCT01732965
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
NCT03718962
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VL-UVA1 vs NB-UVB
Participants will be treated with both VL-UVA and NB-UVB on different areas
Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy
Patients will have different kinds of light shined on different areas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy
Patients will have different kinds of light shined on different areas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects on a stable topical/oral regimen for the past 3 months and continuing on a stable regimen
* Subjects able to understand the requirements of the study
* Subjects able and willing to sign informed consent
Exclusion Criteria
* Subjects receiving any concurrent phototherapy
* Subjects who plan to use tanning parlors or expose themselves to excess sunlight
* Subjects with known photosensitivity disorder
* Subjects with apparent phototoxicity
* Subjects with unstable vitiligo
* Subjects currently using bleaching agents
* Subjects who are pregnant, lactating, or planning on becoming pregnant
* Subjects who in the opinion of the investigator/sub-investigator, are not appropriate candidates for this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iltefat Hamzavi
Director Investigator Initiated Studies
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iltefat Hamzavi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Henry Ford HS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11973
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.